Company news
Neuropace, Inc. news in 2021
Neuropace, Inc.'s news releases, calls and decks from 2021, newest first.
NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference
December 15, 2021
NeuroPace Reports Third Quarter 2021 Financial Results
November 9, 2021
NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy
November 9, 2021
NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021
October 19, 2021
NeuroPace Announces Addition of Lisa Andrade to the Board
October 18, 2021
NeuroPace to Participate in Upcoming Conferences
August 22, 2021
NeuroPace Reports Second Quarter 2021 Financial Results
August 11, 2021
NeuroPace Launches nSight Platform and Partnership with Seizure Tracker™ to Provide Doctors With Personalized Information About Their Patients’ Seizure Burden
August 3, 2021
NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome
June 29, 2021
NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance
June 2, 2021
NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021
May 19, 2021
NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
April 25, 2021
NeuroPace, Inc. Announces Pricing of Initial Public Offering
April 20, 2021